Antibodies against cyclic citrullinated peptides in infectious diseases--a systematic review (Q34129802)

31 July 2017

1 reference

title

Antibodies against cyclic citrullinated peptides in infectious diseases--a systematic review (English)

1 reference

31 July 2017

1 reference

1 reference

Isabella Lima

1 reference

31 July 2017

Mittermayer Santiago

series ordinal

1 reference

31 July 2017

publication date

5 August 2010

1 reference

31 July 2017

published in

Clinical Rheumatology

1 reference

31 July 2017

1 reference

31 July 2017

1 reference

31 July 2017

page(s)

1345-1351

1 reference

The incidence of rheumatoid arthritis in the United Kingdom: results from the Norfolk Arthritis Register

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1544-X

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1544-X

Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1544-X

The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1544-X

Systematic review: accuracy of anti-citrullinated Peptide antibodies for diagnosing rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1544-X

Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1544-X

Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein/peptide antibodies in the diagnosis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1544-X

Diagnostic value of anti-MCV antibodies in differentiating early inflammatory arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1544-X

Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1544-X

Diagnostic utility of anti-cyclic citrullinated peptide and anti-modified citrullinated vimentin antibodies in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1544-X

The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1544-X

Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1544-X

Comparative performance analysis of 4 different anti-citrullinated protein assays in the diagnosis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1544-X

Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1544-X

Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1544-X

Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1544-X

Anti-citrullinated protein antibodies in rheumatoid arthritis: as good as it gets?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1544-X

Antibodies to mutated citrullinated vimentin and disease activity score in early arthritis: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1544-X

Antibody against mutated citrullinated vimentin: a new sensitive marker in the diagnosis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1544-X

Does anti-mutated citrullinated vimentin have additional value as a serological marker in the diagnostic and prognostic investigation of patients with rheumatoid arthritis? A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1544-X

Positive anti-cyclic citrullinated proteins and rheumatoid factor during active lung tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1544-X

The anti-cyclic citrullinated peptide response in tuberculosis patients is not citrulline-dependent and sensitive to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1544-X

Patients with pulmonary tuberculosis are frequently positive for anti-cyclic citrullinated peptide antibodies, but their sera also react with unmodified arginine-containing peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1544-X

Clinical significance of anti-cyclic citrullinated peptide antibodies in Egyptian patients with chronic hepatitis C virus genotype IV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1544-X

Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1544-X

Absence of antibody to cyclic citrullinated peptide in sera of non-arthritic patients with chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1544-X

Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1544-X

Usefulness of anti-CCP antibodies in patients with hepatitis C virus infection with or without arthritis, rheumatoid factor, or cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1544-X

Clinical utility of the anti-CCP assay: experiences with 700 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1544-X

Anti-cyclic citrullinated peptide antibodies in hepatitis C virus associated rheumatological manifestations and Sjogren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1544-X

Absence of antibodies to cyclic citrullinated peptide in sera of patients with hepatitis C virus infection and cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1544-X

A NEW SERUM FACTOR IN PATIENTS WITH RHEUMATOID ARTHRITIS; THE ANTIPERINUCLEAR FACTOR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1544-X

Myelin in multiple sclerosis is developmentally immature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1544-X

The fate of trichohyalin. Sequential post-translational modifications by peptidyl-arginine deiminase and transglutaminases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1544-X

Changing Pattern of Deiminated Proteins in Developing Human Epidermis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1544-X

Citrullination is an inflammation-dependent process

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1544-X

Anticitrulline peptide antibodies (CCP3) in leprosy sera: a negative association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1544-X

Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis a

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1544-X

Anti-cyclic citrullinated peptide antibodies in patients affected by HCV-related arthritis

21 January 2018

1 reference

12 December 2020

The positivity of rheumatoid factor and anti-cyclic citrullinated peptide antibody in nonarthritic patients with chronic hepatitis C infection

1 reference

12 December 2020

Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement

1 reference

12 December 2020

Demonstration of an antiperinuclear factor in patients with rheumatic diseases, liver diseases and lung tuberculosis using fluorescence technic

1 reference

12 December 2020

Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis

1 reference

12 December 2020

Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis

1 reference

12 December 2020

Diagnostic utility of anti-cyclic citrullinated peptide antibodies for rheumatoid arthritis in patients with active lung tuberculosis

1 reference

12 December 2020

Antibodies to citrullinated vimentin are a specific and sensitive marker for the diagnosis of rheumatoid arthritis

1 reference

12 December 2020

Serum markers of rheumatoid arthritis in visceral leishmaniasis: Rheumatoid factor and anti-cyclic citrullinated peptide antibody

1 reference

12 December 2020

The anti-mutated citrullinated vimentin response classifies patients with rheumatoid arthritis into broad and narrow responders

1 reference

12 December 2020

The serological diagnosis of rheumatoid arthritis: antibodies to citrullinated antigens

1 reference

12 December 2020

Anti-cyclic citrulline peptide antibody in non-tuberculous mycobacteria sera: a negative association

1 reference

12 December 2020

A comparison of the frequency of antibodies to cyclic citrullinated peptides using a third generation anti-CCP assay (CCP3) in systemic sclerosis, primary biliary cirrhosis and rheumatoid arthritis

1 reference

12 December 2020

Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides

1 reference

12 December 2020

Value of anti-mutated citrullinated vimentin antibodies in diagnosing rheumatoid arthritis

1 reference

12 December 2020

Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with liver diseases

1 reference

12 December 2020

Anti-cyclic citrullinated peptide antibodies as a discriminating marker between rheumatoid arthritis and chronic hepatitis C-related polyarthropathy

1 reference

12 December 2020

Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach

1 reference

12 December 2020

Meta-analysis: diagnostic value of serum anti-mutated citrullinated vimentin antibodies in patients with rheumatoid arthritis

1 reference

12 December 2020

Absence of cyclic citrullinated peptide antibody in nonarthritic patients with chronic hepatitis C infection

1 reference

12 December 2020

Incidence and characteristics of the antiperinuclear factor in the blood of patients with rheumatoid arthritis and other diseases

1 reference

12 December 2020

10.1007/S10067-010-1544-X

Identifiers

DOI

1 reference

31 July 2017

1 reference